Acumen Pharmaceuticals, Inc.ABOSNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Total earnings after all expenses, taxes, and interest

Latest
$-102.33M
↓ 96% below average
Average (5y)
$-52.23M
Historical baseline
Range
High:$-7.33M
Low:$-102.33M
CAGR
+66.9%
Consistent expansion
PeriodValueChange
2024$-102.33M-95.4%
2023$-52.37M-22.2%
2022$-42.86M+57.4%
2021$-100.61M-1273.5%
2020$-7.33M+7.4%
2019$-7.91M-